WebBoard Members; Grants Committee; Compliance; Acquisitions & Investments; Diversity Equity & Inclusion; Products. Pain Treatments & Joint Preservation; Restorative Therapies; Surgical Solutions; Patients; Physicians. Investigator … She served on the Board of trustees of Duke University from 2003 to 2015, and … Mr. Hawkins was President and CEO of Immucor from Oct 2011 to July 2015. … Michelle McMurry-Heath assumed the leadership of the Biotechnology … She has also served on the Board of Trustees of Edward-Elmhurst Health … Marty Sutter is one of the two founding managing directors of EW Healthcare … WebBioventus Inc. Announces Resignation of Stavros G. Vizirgianakis as Member of the Board of Directors Sep 02. Price target decreased to US$16.40 Aug 12. Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind ... serves as Chief Executive Officer and Member of Board of Managers at Bioventus LLC April 20, 2024 ...
Bioventus Dusts Off IPO Plans as its Medical Device ... - NCBiotech
WebNov 4, 2024 · Bioventus anticipates this growth will stem from its ability to gain substantial market share in multiple surgical applications including wound healing. As of the closing of the transaction, Stavros Vizirgianakis and Patrick Beyer, former members of Misonix’s Board of Directors, have joined the Bioventus Board of Directors. WebApr 6, 2024 · Dive Brief: Bioventus, which makes devices to treat pain and stimulate bone healing, said Ken Reali has stepped down as CEO and director, after the company’s board informed him on Wednesday that it had determined he would “transition from the role,” according to a regulatory filing.; Reali’s departure comes after the company canceled a … ray smothers
Board Members - Bioventus
WebJul 14, 2024 · Mary Kay Ladone Bioventus Board Member Bioventus Appoints Mary Kay Ladone to its Board of Directors DURHAM, N.C., July 14, 2024 (GLOBE NEWSWIRE) - … WebNov 2, 2024 · Nov 2, 2024. A Durham-based health care company that went public earlier this year has completed the acquisition of a New York firm in a deal valued at $518 million. Bioventus (Nasdaq: BVS), which ... WebJul 31, 2024 · Vizirgianakis and Patrick Beyer, both members of Misonix’s board of directors, will join the Bioventus board at the closing of the transaction. ray smock